Dr. Hagins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Wheeler St
Savannah, GA 31405Phone+1 912-356-2953Fax+1 912-356-2465
Education & Training
HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Family Medicine, 1989 - 1992
Morehouse School of MedicineClass of 1989
Certifications & Licensure
GA State Medical License 1992 - 2025
Publications & Presentations
PubMed
- 38 citationsSwitching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Mul...Cissy Kityo, Debbie Hagins, Ellen Koenig, Anchalee Avihingsanon, Ploenchan Chetchotisakd
Journal of Acquired Immune Deficiency Syndromes. 2019-11-01 - 93 citationsBictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 resul...David A. Wohl, Yazdan Yazdanpanah, Axel Baumgarten, Amanda Clarke, Melanie A. Thompson
The Lancet. HIV. 2019-06-01 - 13 citationsSwitching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.Debbie Hagins, Princy Kumar, Michael S. Saag, Anson K Wurapa, Indira Brar
Journal of Acquired Immune Deficiency Syndromes. 2021-09-01
Press Mentions
Switching HIV Regimens Safe in African-AmericansMarch 10th, 2020
First Efficacy Trials on Switch to RPV/FTC/TAF for HIV Yield Positive ResultsSeptember 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
